Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017

C Hiemke, N Bergemann, HW Clement… - …, 2018 - thieme-connect.com
Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug
concentrations in blood to optimize pharmacotherapy. It considers the interindividual …

[HTML][HTML] Molecular targets of cannabidiol in neurological disorders

CI Bih, T Chen, AVW Nunn, M Bazelot, M Dallas… - …, 2015 - Elsevier
Cannabis has a long history of anecdotal medicinal use and limited licensed medicinal use.
Until recently, alleged clinical effects from anecdotal reports and the use of licensed …

Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting

X Ma, X Qu, W Zhu, YS Li, S Yuan… - Proceedings of the …, 2016 - National Acad Sciences
The functional maturation and preservation of hepatic cells derived from human induced
pluripotent stem cells (hiPSCs) are essential to personalized in vitro drug screening and …

The genetic landscape of major drug metabolizing cytochrome P450 genes—an updated analysis of population-scale sequencing data

Y Zhou, VM Lauschke - The Pharmacogenomics Journal, 2022 - nature.com
Genes encoding cytochrome P450 enzymes (CYPs) are extremely polymorphic and multiple
CYP variants constitute clinically relevant biomarkers for the guidance of drug selection and …

The role of pharmacists in personalised medicine: a review of integrating pharmacogenomics into clinical practice

OD Balogun, O Ayo-Farai, O Ogundairo… - International Medical …, 2024 - fepbl.com
This paper explores the transformative role of pharmacists in integrating pharmacogenomics
into clinical practice. Pharmacogenomics, the study of genetic influences on drug response …

AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011

C Hiemke, P Baumann, N Bergemann… - …, 2011 - thieme-connect.com
Therapeutic drug monitoring (TDM), ie, the quantification of serum or plasma concentrations
of medications for dose optimization, has proven a valuable tool for the patient-matched …

Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II

SF Zhou - Clinical pharmacokinetics, 2009 - Springer
Part I of this article discussed the potential functional importance of genetic mutations and
alleles of the human cytochrome P450 2D6 (CYP2D6) gene. The impact of CYP2D6 …

Applications of CYP450 testing in the clinical setting

CF Samer, KI Lorenzini, V Rollason, Y Daali… - Molecular diagnosis & …, 2013 - Springer
Interindividual variability in drug response is a major clinical problem. Polymedication and
genetic polymorphisms modulating drug-metabolising enzyme activities (cytochromes P450 …

Long-term functional maintenance of primary human hepatocytes in vitro

C Xiang, Y Du, G Meng, L Soon Yi, S Sun, N Song… - Science, 2019 - science.org
The maintenance of terminally differentiated cells, especially hepatocytes, in vitro has
proven challenging. Here we demonstrated the long-term in vitro maintenance of primary …

Human hepatocytes with drug metabolic function induced from fibroblasts by lineage reprogramming

Y Du, J Wang, J Jia, N Song, C Xiang, J Xu, Z Hou… - Cell stem cell, 2014 - cell.com
Obtaining fully functional cell types is a major challenge for drug discovery and regenerative
medicine. Currently, a fundamental solution to this key problem is still lacking. Here, we …